Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Bleomycin is a medication primarily used to treat cancer. This includes Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, ovarian cancer, and cervical cancer among others. Typically used with other cancer medications, it can be given intravenously, by injection into a muscle or under the skin. It may also be administered inside the chest to…
History, Applications & Research
Explore the main themes, entities and connections around Bleomycin. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cancer may dna used also primarily treat skin chest side effects pulmonary fibrosis oxygen pleural effusion due lung medication cause
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Bleomycin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Bleomycin | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Bleomycin | ATC code | L01DC01 (WHO) | 1.00 | infobox |
| Bleomycin | Bioavailability | 100% and 70% following intramuscular and subcutaneous administrations, respectively, and 45% following both intraperitoneal and intrapleural administrations | 1.00 | infobox |
| Bleomycin | CAS Number | 11056-06-7 Y | 1.00 | infobox |
| Bleomycin | CAS Number | sulfate: 9041-93-4 Y | 1.00 | infobox |
| Bleomycin | ChEBI | CHEBI:22907 N | 1.00 | infobox |
| Bleomycin | ChEMBL | ChEMBL403664 N | 1.00 | infobox |
| Bleomycin | ChemSpider | 4574226 N | 1.00 | infobox |
| Bleomycin | CompTox Dashboard (EPA) | DTXSID1030862 | 1.00 | infobox |
| Bleomycin | Drug class | Glycopeptide antibiotic | 1.00 | infobox |
| Bleomycin | DrugBank | DB00290 N | 1.00 | infobox |
| Bleomycin | Elimination half-life | two hours | 1.00 | infobox |
| Bleomycin | Excretion | Kidney (60–70%) | 1.00 | infobox |
| Bleomycin | Formula | C55H84N17O21S3 | 1.00 | infobox |
| Bleomycin | KEGG | D07535 N | 1.00 | infobox |
| Bleomycin | KEGG | sulfate: C15773 N | 1.00 | infobox |
| Bleomycin | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Bleomycin | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Bleomycin | Legal status | US: ℞-only | 1.00 | infobox |
| Bleomycin | Legal status | EU: Rx-only | 1.00 | infobox |
| Bleomycin | License data | US DailyMed: Bleomycin | 1.00 | infobox |
| Bleomycin | MedlinePlus | a682125 | 1.00 | infobox |
| Bleomycin | Molar mass | 1415.56 g·mol−1 | 1.00 | infobox |
| Bleomycin | Pregnancy category | AU: D | 1.00 | infobox |
| Bleomycin | PubChem CID | 5460769 | 1.00 | infobox |
| Bleomycin | Routes of administration | intravenous, intramuscular, subcutaneous, intrapleural | 1.00 | infobox |
| Bleomycin | Trade names | Blenoxane | 1.00 | infobox |
| Bleomycin | UNII | 40S1VHN69B | 1.00 | infobox |
| Bleomycin | UNII | sulfate: 7DP3NTV15T Y | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.